Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$91.49 - $104.64 $77,857 - $89,048
-851 Reduced 2.64%
31,440 $2.9 Million
Q1 2023

May 08, 2023

SELL
$92.92 - $109.35 $550,551 - $647,898
-5,925 Reduced 15.5%
32,291 $3.12 Million
Q4 2022

Feb 21, 2023

SELL
$84.9 - $102.89 $375,682 - $455,288
-4,425 Reduced 10.38%
38,216 $3.73 Million
Q3 2022

Nov 03, 2022

SELL
$90.51 - $207.38 $2.11 Million - $4.84 Million
-23,332 Reduced 35.37%
42,641 $3.91 Million
Q2 2022

Jul 15, 2022

BUY
$87.94 - $101.67 $35,351 - $40,871
402 Added 0.61%
65,973 $6.1 Million
Q1 2022

May 06, 2022

SELL
$85.56 - $107.12 $442,858 - $554,453
-5,176 Reduced 7.32%
65,571 $6.6 Million
Q4 2021

Jan 31, 2022

SELL
$97.41 - $116.74 $178,844 - $214,334
-1,836 Reduced 2.53%
70,747 $7.48 Million
Q3 2021

Oct 26, 2021

BUY
$101.72 - $114.56 $40,688 - $45,824
400 Added 0.55%
72,583 $7.69 Million
Q2 2021

Aug 03, 2021

SELL
$100.62 - $116.66 $962,832 - $1.12 Million
-9,569 Reduced 11.7%
72,183 $7.73 Million
Q1 2021

May 14, 2021

SELL
$95.11 - $111.11 $1.2 Million - $1.4 Million
-12,574 Reduced 13.33%
81,752 $8.24 Million
Q4 2020

Feb 12, 2021

SELL
$101.34 - $117.74 $143,700 - $166,955
-1,418 Reduced 1.48%
94,326 $10.3 Million
Q3 2020

Nov 13, 2020

SELL
$95.79 - $111.95 $375,592 - $438,955
-3,921 Reduced 3.93%
95,744 $9.85 Million
Q2 2020

Aug 18, 2020

SELL
$90.75 - $104.91 $88,390 - $102,182
-974 Reduced 0.97%
99,665 $9.85 Million
Q1 2020

May 21, 2020

BUY
$79.09 - $114.05 $607,806 - $876,474
7,685 Added 8.27%
100,639 $9.14 Million
Q4 2019

Feb 18, 2020

SELL
$77.9 - $98.54 $35,055 - $44,343
-450 Reduced 0.48%
92,954 $9.01 Million
Q3 2019

Nov 19, 2019

SELL
$74.21 - $82.92 $11,725 - $13,101
-158 Reduced 0.17%
93,404 $7.36 Million
Q2 2019

Aug 16, 2019

BUY
$68.24 - $75.87 $198,373 - $220,554
2,907 Added 3.21%
93,562 $7.06 Million
Q1 2019

May 15, 2019

BUY
$65.72 - $71.66 $40,483 - $44,142
616 Added 0.68%
90,655 $6.28 Million
Q4 2018

Feb 22, 2019

SELL
$61.31 - $73.73 $214,217 - $257,612
-3,494 Reduced 3.74%
90,039 $5.87 Million
Q3 2018

Nov 15, 2018

SELL
$71.66 - $82.93 $24,722 - $28,610
-345 Reduced 0.37%
93,533 $6.81 Million
Q2 2018

Aug 14, 2018

BUY
$58.93 - $74.24 $5.53 Million - $6.97 Million
93,878 New
93,878 $6.68 Million

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.